Why Anthropic’s IPO Is Too Important to Fail
Anthropic’s potential IPO could test whether AI companies can turn exceptional growth, high infrastructure spending, and private valuations into durable public-market businesses.
Toyota Kei Pickup: Could the Scion KEI-01 Reach the U.S.?
The reported 2028 Scion KEI-01 could bring a 25-mph kei-style pickup to the U.S., but regulations, pricing, specifications, and availability remain unconfirmed.
Nasdaq Futures Rise as CoreWeave Earnings Lift AI Stocks
Nasdaq and S&P 500 futures rose after CoreWeave's reported earnings beat revived optimism about AI infrastructure demand, though prices and key figures require verification.
FDA GLP-1 Eye Warning: What Ozempic Users Should Know
Reports describe a potential FDA warning about rare vision loss linked to GLP-1 drugs. Learn the symptoms, evidence and steps patients should take.
Gemini 4 Carbon Rolls Out Alongside Argon
Gemini 4 Carbon is reportedly rolling out in the Gemini app for some AI Ultra subscribers, while Argon remains available and a regional $2 promotion emerges.
Apple Support Community Closing November 20: What to Know
Apple will permanently close the Apple Support Community on November 20. Learn what may happen to posts and points and where to get support afterward.
Spotify AI DJ Adds New Voices and Less Chatter
Spotify is reportedly expanding AI DJ with regional voices, distinct personalities, and a less-chatter option that gives listeners more control over commentary.
Adobe’s New AI Tools for Photoshop and Premiere Pro
Adobe is expanding AI across Photoshop, Premiere Pro, and Firefly, with Firefly Builder and planned MCP support pointing toward agent-assisted creative workflows in 2027.
Speech Changes and Dementia Risk: What Research Shows
Subtle changes in speech may help researchers estimate dementia risk, but speech analysis cannot diagnose dementia or replace a clinical evaluation.
Semaglutide May Reduce Knee Pain From Osteoarthritis
A major trial found that semaglutide reduced knee pain and improved function in adults with obesity and knee osteoarthritis, likely through substantial weight loss.